3158 results for «227»
3158 results
Mastering techniques from basic to complex - Advanced TAVI
13 Feb 2026 – From PCR Tokyo Valves 2026
Explore advanced TAVI techniques focusing on challenging patient subsets such as those with small annuli, bicuspid valves, and valve-in-valve procedures. This session reviews valve selection and procedural optimization to enhance clinical outcomes in complex scenarios.
Design that delivers the future of TAVI
13 Feb 2026 – From PCR Tokyo Valves 2026
This session addresses future-oriented TAVI valve design and procedural planning. It highlights supra-annular valve benefits, strategies for managing concomitant coronary artery disease, and redo-TAVI approaches to ensure long-term durability and optimal hemodynamics.
Mastering LAA closure: a step-by-step case experience
14 Feb 2026 – From PCR Tokyo Valves 2026
This session presents a step-by-step, case-based approach to mastering left atrial appendage (LAA) closure. It covers pre-procedural planning, device-specific strategies, complication prevention, and complex bailout techniques such as leak closure with coiling or dual-device implantation.
Patient-tailored treatment for bicuspid valve
14 Feb 2026 – From PCR Tokyo Valves 2026
This session focuses on patient-tailored treatment for bicuspid aortic valve stenosis, providing comprehensive insights into the evidence base for TAVI in this population. It discusses critical considerations for valve selection and sizing, and highlights anatomical features that may pose challenges for TAVI procedures. Case studies illustrate...
Mastering mitral TEER: guidelines, complex cases, and Asia Pacific insights
14 Feb 2026 – From PCR Tokyo Valves 2026
This session provides an in-depth analysis of mitral transcatheter edge-to-edge repair (TEER) in light of the 2025 ESC Valvular Heart Disease guidelines. It addresses optimal timing and treatment strategies for severe heart failure beyond established trials, and explores technical solutions for complex anatomies. Special attention is...
Mitral TEER masterclass
14 Feb 2026 – From PCR Tokyo Valves 2026
This Mitral TEER masterclass focuses on addressing unique anatomical challenges encountered in Asian populations. The session covers device strategies and techniques tailored for complex anatomies, offering practical tips to minimize complications and improve procedural outcomes through detailed case analyses including small hearts, commissural prolapse with calcification,...
Real world outcomes and strategies for optimal TEER across diverse DMR anatomies
14 Feb 2026 – From PCR Tokyo Valves 2026
This session delves into the real-world complexities of degenerative mitral regurgitation (DMR) and presents advanced strategies for transcatheter edge-to-edge repair (TEER) using the PASCAL device. Participants will explore the latest registry data, device selection criteria, and tactical approaches to manage diverse and challenging DMR anatomies, aiming...
All you need to know about redo TAVI
15 Feb 2026 – From PCR Tokyo Valves 2026
This comprehensive session addresses the complexities of redo Transcatheter Aortic Valve Implantation (TAVI). It covers the full spectrum from pre-procedural analysis—including coronary obstruction risk and valve sizing—to procedural strategies like leaflet modification and optimal positioning. Post-procedural management including antithrombotic therapy and patient-prosthesis mismatch are also examined,...
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure
04 Nov 2021
The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.
Author
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure
06 Nov 2021
TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.
Author
The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy
17 Sep 2022
Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.
Author
Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025
21 May 2025
Coronary arteries
30 Oct 2017
The coronary arteries arise from the aortic sinuses. Read more...
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
A large-scale, randomized trial of orbital atherectomy vs. conventional balloon angioplasty in severely calcified coronary arteries prior to DES implantation (ECLIPSE)
30 Oct 2024
Nicola Ryan provides her take on the ECLIPSE trial presented by Ajay J. Kirtane at TCT 2024 in Washington.
Author
Percutaneous transseptal transcatheter mitral valve replacement using a dedicated balloon-expandable valve: 1-year outcomes from the ENCIRCLE trial using the SAPIEN M3
27 Oct 2025
Jonathan Curio provides his take on the ENCIRCLE Trial presented by David Daniels at TCT 2025 in San Francisco.
Author
NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation
01 Sep 2024
Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.
Author
Author
Author
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
30 Oct 2024
Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.
Author
